Sign in
CompletedNo phase

Identification of Oral Lesions Through an Autofluorescence System

Key facts

Who runs it
Federico II University
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
200 people enrolled
Started
1 Jun 2023
Ended
1 Oct 2024
Type of study
Interventional
Treatments tested
  • Screening examination
Record updated
2 September 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Male and female
  • Age ≥ 18 years
  • Non-smokers and smokers

Who cannot take part

  • Cancer patients
  • Patients presenting a histological diagnosis of oral mucosal dysplasia/carcinoma

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of the study will be to evaluate the efficacy of a tissue autofluorescence detection system as an aid to clinical screening in identifying lesions of the oral mucosa. The screening process will be performed by 3 clinicians with a different level of experience. Sensitivity and specificity tests will be conducted.

The group in the trial

  • Screening examinationTreatment being tested

    All patients will undergo a screening examination (with or without GOCCLES ® glasses) by all three operators.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Use of a Tissue Autofluorescence Detection System for Identification of Oral Mucosal Lesions
Record updated
2 September 2026